BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Mar 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-02-27

Reporting Person: Cohen Fred E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-27	Common Stock	A	857	$10.20	Acquired	102314	Direct

Footnotes

F1: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $8,750.